August 13, 2025 | Account Executive, Artworker, Team, graphic designer, new
Cuttsy+Cuttsy is excited to announce the addition of three talented professionals to the team: Flo, an enthusiastic Account Executive; Vicki, a creative Graphic Designer; and Jo, a detail-driven Artworker

We’re excited to announce three brilliant new additions to the Cuttsy+Cuttsy team this month, each brining unique talents and fresh perspectives to help us deliver meaningful, impactful work across all our projects.
Joining us are:
Commenting on the new appointments, Managing Director Harriet Karia said, “We’re delighted to welcome Flo, Vicki and Jo to the team. They bring fresh ideas, individual strengths and a shared drive to make a difference. I’m looking forward to the impact they’ll have as we continue creating work that really matters, especially for patients.”
These new appointments reflect our commitment to building a talented and diverse team that drives excellence in everything we do. We’re confident Flo, Vicki, and Jo will bring valuable perspectives and skills to their roles, and we’re eager to see the impact of their work.
This content was provided by Cuttsy + Cuttsy
Company Details
Latest Content from Cuttsy + Cuttsy
Explore how pharma can help patients and patient organisations prepare for meaningful involvement in EU HTA without shaping their contribution.
Explore why involving patients early in Joint Scientific Consultations is critical to shaping the outcomes measured in clinical trials.
Explore why long-term clinical trial engagement is a behavioural challenge, showing how proactive support from site teams can help participants stay connected, confident and committed throughout a study.
Patients are often most honest outside the clinic—revealing vital insights that can help clinical trial teams build trust, improve participation and collect better data.
Patient-relevant outcomes sit at the heart of the EU HTA reforms, but ensuring they reflect lived experience requires you to look beyond what traditional clinical endpoints measure.
Exploring how empathetic, patient-centred communication can make planned treatment breaks easier to discuss as part of cancer care.
The EU HTA reforms give patients a formal role in assessing new medicines, but meaningful involvement requires more than simply offering them a seat at the table.
As clinical trials accelerate, clear, accessible consent is essential to help participants understand, engage with and remain in a study.
Older trial participants aren’t rejecting digital technology — they’re rejecting poorly designed, inaccessible experiences that make participation harder.
Key takeaways from the Patient Centricity and Engagement conference, exploring how trust, inclusion and meaningful partnership can help turn patient engagement from intention into action.
